RedHill Biopharma | Eiendeler

Created with Highcharts 10.1.0Chart context menu


Assets Endring Dato
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 123.52M 13.35M 2024-09
Cronos Group USD 1.17B 17.82M 2024-12
Intra Cellular Therapies USD 1.37B 42.47M 2024-12
RedHill Biopharma USD 22.02M 4K 2024-06



RedHill Biopharma Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.